Is lack of modelling in LMM normal?

In the LMM (Lower Middle Market) space, the lack of heavy modeling, such as DCFs or LBOs, is not uncommon. Based on the most helpful WSO content, here are some insights:

1. Nature of LMM Transactions:

   • LMM deals often focus on simpler valuation methods like LTM EBITDA multiples and precedent transactions. This is because buyers and sellers in this space prioritize straightforward, market-driven metrics over complex theoretical models.
   • Forecasting and detailed modeling are typically less emphasized unless required for specific due diligence (DD) requests.

2. Sell-Side Focus:

   • Since your firm primarily handles sell-side transactions, the modeling requirements are naturally lighter. Sell-side processes in the LMM often revolve around preparing marketing materials, managing buyer interactions, and ensuring smooth deal execution rather than building intricate models.

3. Should You Be Concerned?

   • If your goal is to lateral to a larger firm or move upstream (e.g., MM or BB), the lack of modeling exposure could be a concern. Larger firms often expect strong technical skills, including proficiency in DCFs, LBOs, and other advanced modeling techniques.
   • However, your strong deal flow and exposure to the transaction process are valuable experiences that can still position you well for a move.

4. Actionable Steps:

   • Self-Study: Consider leveraging resources like WSO's financial modeling courses (e.g., DCF, LBO, and 3-statement modeling) to build your technical skills independently.
   • Networking: Connect with professionals in MM or BB firms to understand their expectations and tailor your preparation accordingly.
   • Highlight Your Strengths: When lateraling, emphasize your deal experience, client interaction, and understanding of the transaction process while addressing any technical gaps proactively.

In summary, the lack of modeling in LMM is typical, but if you're aiming to move upstream, taking proactive steps to enhance your technical skills will be crucial.

Sources: Biotech finance part 2: valuation methodologies and modeling considerations, Lack of diversity in Banking/Finance, Feel Like I Got Conned - Small No-Name Boutique, Biotech finance part 2: valuation methodologies and modeling considerations, Financial modelling on the buyside